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A B S T R A C T
In this mini-review we present recent data about origin of GABA-ergic (gama-aminobutyric acid) neurons in the
mammalian forebrain, including the diencephalon and telencephalon. The interest in GABA-ergic neurons, which in ce-
rebral cortex mostly correspond to local circuit neurons (interneurons), has increased in the past decade. Many studies
have shown that in lower mammals all hippocampal and almost all neo-cortical GABA-ergic neurons are born in the
specific region named ganglionic eminence, and not locally in proliferative layers all around telencephalic vesicle. The
ganglionic eminence, that represents a region with thick proliferative-subventricular layer in the ventral (basal) part of
telencephalon, was classically thought to give neurons to basal ganglia and septal nuclei, whereas proliferative layers of
dorsal telencephalon give neurons to cerebral cortex including hippocampus. It was thought that neurons migrate from
proliferative layer to their target region following a radial orientation. However, data in lower mammals showed that
this is the case only for glutamatergic principal cells, i.e. projection neurons. GABA-ergic neurons use long distance
tangentional migration, parallel to pial surface to reach, from ganglionic eminence, their targeting layer in the cerebral
cortex. Especially intriguing, but frequently neglecting, several studies suggest that mammalian evolution might use dif-
ferent developmental rules to provide GABA-ergic neurons to an expending brain. In this review we focus on specific
events underlying GABA-ergic neuron development in human and non-human primates. Disturbances of the GABA-
ergic network are found in many neurological and psychiatric disorders, some of them might result from altered produc-
tion or migration of these neurons during development. Therefore, it is crucial to understand human-specific mecha-
nisms that regulate the development of GABA-ergic neurons.
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Introduction
The forebrain comprises a complex set of structures
that derive from the most anterior region of the neural
tube, the prosencephalon1–7. The prosencephalon con-
sists of the diencephalon and telencephalic vesicles,
which emarginated from the dorsal part of the rostral
diencephalon. The telencephalon includes two major re-
gions: the pallium (roof), and the subpallium (base). The
pallium gives rise to the cerebral cortex and hippocam-
pus, whereas the subpallium gives rise to basal ganglia
and septal nuclei. Two major neuronal types are pro-
duced in proliferative layers of forebrain8, projectional
neurons and local circuit neurons (interneurons). In ce-
rebral cortex projectional neurons are mainly glutama-
tergic9,10 whereas interneurons synthesize mainly GABA
(gama-aminobutyric acid) that is major inhibitory neuro-
transmiter in mature (adult) brain11–19.
The interneurons comprise 20 to 30% of cortical neu-
rons serving an instrumental role in modulating cortical
output20–47. These functions are conducted by a remark-
able diversity of distinct subtypes that are distinguished
by axonal and dendritic morphology, biochemical mark-
ers, connectivity and physiology. During mammalian,
and especially primate evolution number and complexity
of GABA-ergic neurons increased more than is the case
to projection neurons. Recent data showed that GABA-
ergic neurons in the forebrain have different mecha-
nisms of proliferation and migration compared to gluta-
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matergic projectional neurons21,22,48–53, and even more;
there are significant changes during mammalian evolu-
tion regarding origin of cortical and thalamic GABA-
ergic neurons54–57. Therefore, in this review we will focus
on two aspects of evolutionary changes in GABA-ergic
neuron origin in the forebrain, the origin of GABA-ergic
neurons in cerebral cortex and of the GABA-ergic neu-
rons in thalamic nuclei.
Origin of GABA-ergic neurons in
mammalian thalamus
During brain evolution, considerable enlargement of
the cortical areas of the cortex is accompanied by an in-
crease of corresponding thalamic nuclei in the dien-
cephalon55,58–67. The number of neurons increases prefer-
entially in limbic and association group of nuclei, whereas
that in the specific relay nuclei appears to be conserved.
The most remarkable progression is present in dorsal
human thalamic nuclei connected with associative cortex
(e.g. pulvinar nucleus, mediodorsal nucelus), that are in
relative size even much larger than those in other pri-
mates. In addition, the increase in neuron number is not
proportional for all neuronal types, so there is a relative
increase in number of GABA-ergic neurons in ascend of
evolution. For example, in rodents, there is a lack of
GABA-ergic neurons in dorsal thalamic nuclei, except in
lateral geniculate nucleus. In addition, the percentage of
these neurons in ventrobasal thalamic nuclei is much
lower than in higher mammals. In primate brain, GABA-
ergic neurons represent approximately 30% of the neu-
rons in each thalamic nucleus54,68,69.
During the embryonic period in human (first 2 months
of gestation), the wall of the thalamus, similar to that of
all neural-tube derivated regions, includes the ventricu-
lar, intermediate and marginal zones7,8. Experimental
autoradiographic studies in mammals demonstrated that
all thalamic neurons arise from the diencephalic ventric-
ular and subventricular zones70–75, distinct from the te-
lencephalic proliferative layers3,7,8. In human fetuses, the
comparative histological analyses together with mea-
surements of supravital incorporation of tritiated thymi-
dine indicated that the thalamic neurons were generated
during the embryonic and early fetal period of develop-
ment7,8,76–79.
However, Rakic and Sidman77 found that the major
period of human pulvinar growth was from the eigh-
teenth to the thirty-fourth week of gestation, when the
diencephalic proliferative layers apparently no longer
generate neurons, while the ganglionic eminence attains
its maximal size and proliferative activity7,8,54,55,80,81. Re-
sults of our group described in human fetuses in detail a
transient structure, the gangliothalamic body, extending
from the ganglionic eminence to the thalamus. The gan-
gliothalamic body was well developed from the eigh-
teenth to the thirty-fourth week of gestation in all rostro-
caudal thalamic regions, containing a streams of bipolar
cells in the tangential direction, which suggests that they
are migrating to a wide range of thalamic nuclei81. Some
of thalamic nuclei may gain new neurons in the period
that postdates the initial outgrowth and even penetra-
tion of the thalamic fibers into the cortical plate82–110 sug-
gested that the ganglionic eminence probably supplies
additional local circuit neurons.
Direct evidence in human brain that cells actually mi-
grate from the ganglionic eminence to the thalamus
came from Letini} and Rakic study54. Using vital dye la-
beling in organotypic slice cultures they show that in hu-
man brain, a contingent of neurons migrate from the
ganglionic eminence of the ventral telencephalon to the
dorsal thalamic association nuclei of the diencephalon,
while in monkeys and mouse this was not the case. These
later findings are supported by previous studies per-
formed in other mammalian species that did not ob-
served such telencephalo-diencephalic migration8. How-
ever Kornack and collaborators111 described a discrete
telencephalo-diencephalic cell migration in the develop-
ing monkey brain. Using retroviral-mediated gene trans-
fer analysis, these authors showed that during late gesta-
tion, the posterior thalamus gains new cells that arise
from nearby mitotically active telencephalic proliferative
layers, and translocate into the diencephalon. In contrast
to human fetal brain, gangliothalamic body was not ob-
served, because the number of cells traveling from telen-
cephalon to diencephalon in the monkey is too small to
form a distinct structure.
All these data showed significant changes in the neu-
ronal organization of thalamic GABA-ergic circuitry through
mammalian evolution, with new migration pathways in-
volved. In addition, they suggest that during mammalian
brain evolution regions connected to each other anatomi-
cally and functionally co-evolve58,59.
Origin of GABA-ergic neurons in cerebral
cortex of nonprimate mammals
Classical studies, as well as modern retroviral lineage
analyses, concur to establish that projection neurons, in
all species examined, originate in the ventricular layer
zone (VZ) of the dorsal telencephalon and migrate along
radial glial fibers, crossing the intermediate zone (IZ), to
the overlying cortical plate8,112–133. Data from Emx1IREScre
mouse2,134 showed that radial glia, Cajal-Retzius cells,
glutamatergic neurons, astrocytes, and oligodendrocytes
of most pallial structures originate from pallial pro-
liferative layers135.
However, it is well recognized that cells disperse in
the forebrain in patterns that do not coincide with the
plane of the glial fiber system8,136–142. Lineage experi-
ments indicate that separate progenitors give rise to cor-
tical glutamatergic projection neurons and GABA-ergic
neurons143–147 and that clones of GABA-ergic neurons are
tangentially dispersed, whereas radially arranged clones
are formed primarily of projection neurons57,148–151. Im-
munohistochemical analysis has revealed that post-mi-
totic migrating like GABA-containing neurons within
the intermediate zone and lower marginal zone have a
morphology and orientation consistent with a lateral to
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medial migration, from the ganglionic eminences into the
neocortex152,153. Studies of cultured brain slices have re-
vealed that cells containing GABA migrate tangen-
tially from the ventral telencephalon into the neocor-
tex49,55, 154–169. In addition, several lines of knockout mice
that display abnormalities in proliferative tissues of the
ventral telencephalon show marked reductions in the
numbers of cortical GABA-immunoreactive neurons pre-
sent in the neocortex at birth. These include mutants for
the transcription factors Dlx1 and Dlx2 that show 75%
decrease in neocortical GABA neurons at P0 (postnatal
day)155,170; Nkx2.1 – 50% decrease in neocortical GABA-
ergic cells at E18.5 (embryonic day)171; andMASH1 that
show 50% decrease in neocortical GABA-ergic neurons at
E18.5172,173.
These studies have provided compelling evidence that
GABA-expressing cells are derived from the ganglionic
eminences of the ventral telencephalon and migrate tan-
gentially through the intermediate zone into the cerebral
cortex (Figure 1). It was shown that ganglionic eminence
gives also rise to GABA-ergic projection neurons of the
striatum and globus pallidus80,159,174–177, as well as to
GABA-ergic neurons of the olfactory bulb155,162. The gan-
glionic eminence may also generate the cholinergic pro-
jection neurons of the nucleus basalis and cholinergic
interneurons of the striatum80,159.
Division of the developing telencephalon into progeni-
tor domains in which neuronal fate may be restricted to a
particular neurotransmitter phenotype questioned which
mechanismsmay control region-specific neurogenesis and
neurotransmitter specification. Mash-1 and Dlx1/2 ex-
pression was showed to be major transcription factors in-
volve in the specification of GABA-ergic phenotypes in
the forebrain. The basic helix– loop–helix gene Mash1
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Fig. 1. Frontal section of monkey brain stained with calretinin antibody (a,b) at stage of E47 (embryonic day) (a) and stage E56 (b). Note
unipolar migrating like cells leaving ganglionic eminence (GE) and entering the intermediate zone (IZ) in tangentional orientation (a).
Note intensive calretinin staining in the subplate (sp) located bellow the cortical plate (cp). At later stages the subventricular (SVZ) and
intermediate zone contain numerous tangentionally and nonradially oriented unipolar migrating like cells, whereas no cells were
found in the ventricular zone (VZ) (b). Golgi staining of frontal sections of the human fetal brain at 22. week of gestation (c,d). Note the
same distribution of nonradially oriented migratory like cells in the dorsal telencephalic wall (c) as in the monkey brain (b). At that
stage numerous unipolar migrating like cells are still leaving the ganglionic eminence and entering the intermediate zone (d).
plays an important role in neurogenesis of the stria-
tum80,172,173,175,178.Ectopic expression of Mash1 in the cor-
tex induces expression of GAD67 (glutamate decarboxyl-
ase)179. In addition, the transcription factor Dlx2 induces
GAD67 and GABA expression when expressed within
cortical cells from Dlx1/Dlx2 mutant mice155,170, 174,180–183
or in slices of wild-type prenatal neocortex184,185. That in
single mutants for this two genes no complete absence of
GABA-ergic cells was described155,170–173, it is possible
that there are other genes that could specify phenotype
for some subpopulation of GABA-ergic neurons in the
forebrain.
Origin of GABA-ergic neurons in cerebral
cortex of macaque monkey and humans
The primate neocortex displays an exponential in-
crease, in size compared with that of other mammals,
whereas subcortical structures show only linear increa-
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Fig. 2. Schematic drawings of changes in origin and routes of GABA-ergic neuron migration in forebrain based on the literature data
and showed on schematised frontal section of human fetus at 14. week of gestation at the level where ganglionic eminence (GE), tha-
lamus (Th), hypothalamus (Hyp), caudate nucleus (S), putamen (P) and corpus callosum (CC) is present. During early embryonic stages
(a,b) the major source of cortical GABA-ergic neurons is the ganglionic eminence and the neurons migrate tangentionally in the cortex
(red arrows); in rat (a) it seems that all GABA-ergic neurons are produced in the ganglionic eminence, whereas in monkey (b) prolifera-
tion of GABA-ergic neurons is very early present also in the pallial (cortical) proliferative on the most dorsal part of the telencephalon
(blue arrows). Note, that in the diencephalon of the rat (a) GABA-ergic interneurons are produced only in the ventral diencephalic
proliferative layers (red arrows), so that dorsal thalamic nuclei do not contain GABA-ergic neurons. In the monkey (b) GABA-ergic
diencephalic neurons are produced also in dorsal proliferative layers (blue arrows), so they are found in the dorsal thalamic nuclei too.
It is supposed that dynamics of interneuron production found in the monkey (b,d) is also present in the human fetal brain. Later on dur-
ing gestation (c,d) more cells are produced in dorsal proliferative layers, so that even in rodent (c) some small percentage of the GABA-
ergic neurons is produced in dorsal proliferative layers, whereas according to Letini} and collaborators55 in human (d) the number of
dorsal producing GABA-ergic neurons is increasing, whereas in the ganglionic eminence production is decreasing. Regarding to this
suggestion in more later stages of neurogenesis (e), that were not present in rodent brain, the major proliferation of cortical GABA-ergic
neurons is present in dorsal (cortical) proliferative layers, and not in the ganglionic eminence. However, the most recent preliminary
data of our group211 suggest another possibility, because size of ganglionic eminence as density of migrating like cells leaving it has
reached the peak around 22. week of gestation (f). Note that proliferation of neurons in the diencephalic proliferative layers is in the
middle of gestation decreasing, and later is not present at all. In human (e,f), there is a huge stream of cells invading thalamic nuclei
from the ganglionic eminence (green arrows), whereas in monkey only few neurons were found to undertake this route (d). In lower
mammals this is not present (c).
ses60,186–188. Such evolution of the neocortex disturbs the
scaling of shared developmental processes between corti-
cal and subcortical structures (Figure 2). Therefore, one
can imagine that an exclusive ventral telencephalic pro-
duction of cortical GABA-ergic neurons as in rodents,
would imply that in primate these neurons have to travel
very long distances before reaching their targeted layer.
Interestingly the study of Letini} and collaborators55 pro-
vides evidence that mammalian evolution uses different
developmental rule to resolve this issue. The authors
demonstrate that the dorsal telencephalic proliferative
layers are the major source of neocortical GABA-ergic
neurons in humans. The study identifies a distinct popu-
lation of Mash1-expressing progenitors for GABA-ergic
neurons in the human dorsopallial proliferative layers.
Mash1 was present only in progenitors that give rise to
cortical plate neurons that express GABA and Dlx, and
not in progenitors that give rise to pyramidal neurons. In
addition several studies have shown that an ectopic
Mash1 expression in rodents is sufficient to upregulate
Dlx1/2 in neocortical neurons, whereas an ectopic Dlx ex-
pression may induce the GABA-ergic phenotype in the
same cells155,170,180–183. This data suggest that Mash1
transcription factor may induce GABA-ergic neuronal
production in the human dorsopallial VZ/SVZ by upre-
gulating Dlx genes.
Letini} and collaborators55 also suggested that this
dorsal telencephalic origin of GABA-ergic neurons might
be humanspecific, as the telencephalo-diencephalic mi-
gration of GABA-ergic neurons. This hypothesis was
based also on the fact that rodents and primates display
significant differences in production of cortical cells. For
example most retroviral labelling studies indicate that
SVZ in rodent is predominantly a gliogenic compart-
ment8,189–194, in contrast, the SVZ is a main region for
neurogenesis in monkey and human55,192,193,195,196. How-
ever, reports8,154,197,198 suggest that in rodents some, Dlx
expressing progenitors in the SVZ of the dorsal telen-
cephalon derive from truly pallial’ progenitors, as has
been proposed to occur in humans55, indicating that the
idea that the source of GABA-ergic neuron in the cortical
VZ/SVZ is unique to humans needs to be counterbal-
anced.
In rodent disruptions of ganglionic eminence devel-
opment results in only partial losses of cortical GABA-
ergic cells154,171,172,174,199 and palial (cortical) progenitor
cells are able to generate GABA-expressing neurons in
vitro143,200–202. It should be mentioned that the produc-
tion of GABA-ergic neurons in the rodent cortical (pa-
lial) proliferative layers accounts at best for only a
small fraction of the interneurons present at matu-
rity49. In the ferret, neurons destined for neocortical
layers II and III continue to be generated during early
postnatal life203–205. The spatial origin of these cells
within the telencephalon49 showed that very few (less
than 5%) of them labeled for the interneuron markers
GABA or GAD67 originate from the cortical prolife-
rative layers.
Data obtained in transgenic mouse suggest that in ro-
dents more than 95% of cortical GABA-ergic cells express
Dlx5/6 at some stage of their development and suggesting
that most cortical GABA-ergic neurons are derived from
the subpallium184,185,206,207. However, our results showed
that in macaque as in human a large proportion of GA-
BA-ergic neurons are produced in the proliferative layers
of the dorsal telencephalon208,209.
Therefore, all this data demonstrate different produc-
tion sources for cortical as well as diencephalic GABA-
ergic neurons during evolution. The dorsal telencephalic
origin, in addition to the ventral one for cortical GABA-
ergic neurons in humans might reflect a boosting of
pre-existing developmental mechanisms. The novel sour-
ce of Mash1 progenitors in humans might arise from the
evolutionary duplication of comparable cells in the gan-
glionic eminence. Some light Mash1 immunoreactivity
observed in dorsal proliferative layers during neuroge-
nesis in mice210. Such data support this hypothesis.
The possibility that some of Mash1-expressing pro-
genitors in the primate neocortical VZ/SVZ in fact ar-
rived from the ganglionic eminence at earlier embryonic
stages and continue to divide locally in neocortical proli-
ferative layers was mentioned by Letini} and collabo-
rators55. However, this and our208,209 data strongly sug-
gest that neocortical GABA-ergic neurons are born in the
VZ/SVZ of the dorsal telencephalon as a distinct neu-
ronal stem cell lineage. In favor of this hypothesis are
some experimental results from studies in rodents; it
seems that a single genetic switch is all that it takes —
misexpression of Mash1 in cortical neurons results in
their transformation to the interneuron type179. Also, af-
ter 14.5 embryonic day (E) in the mouse, many Dlx-ex-
pressing cells appear to migrate from the subcortical SVZ
directly into the SVZ of the neocortex. Some of these cells
express the postmitotic neuronal marker Tuj1 and at
E16.5 they are not proliferating based on the lack of la-
beling with antibodies against proliferating cell nuclear
antigen (PCNA)154. The slice transplant experiments of
E14.5 ganglionic eminence, pulsed with BrdU for 4 hours
before fixation at 2 days in vitro, also found that gangli-
onic eminence cells did not proliferate after migration
into the cortex198. Surprisingly, although Dlx1 expressing
cells in the cortical SVZ were negative for PCNA at
E16.5, at P0 many of them co-label with PCNA and these
appear to be proliferating154. So it seems that Mash1 ex-
pression in a minority of cortical progenitors induces Dlx
genes. A slice transplantation assay154, modified by the
use of GFP-expressing donor tissues198 showed that large
number of cells from the subcortical donor tissue mi-
grated into the cortex of the host slice154,198. Although
many of these cells migrated into the cortical prolife-
rative layers, and although a large number of the cortical
proliferative layers cells incorporated BrdU, double la-
beled cells were extremely rare at any of the three ages.
Migration of GFP-labeled cells (post-mitotic neurons)
from the ganglionic eminence into the cortical proli-
ferative zones was robust, as was production in the corti-
cal proliferative layers. However, the percentage of GFP
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expressing cells that incorporated BrdU within the corti-
cal proliferative layers remained extremely small, show-
ing that GABA-ergic neurons produced in cortical-pallial
proliferative layers originate from truly cortical, »pallial«
progenitors, and not from progenitors invading this layer
from ganglionic eminence.
All above presented data are in line with the interpre-
tation that large dorsal (pallial-cortical) production of
interneurons in primate cortex is an „answer« to an in-
creased number of GABA-ergic neurons to an expanding
neocortex However, our recent preliminary findings, de-
scribing tangentional migration in the human fetal brain
during second trimester of gestation, suggest another
hypothesis211. We found that at the 22. week of gestation
density of tangentionally migrating cells increased com-
pared to earlier stages, especially in the stream leaving
the ganglionic eminence, that during this period shows
an increase in size. Increase in number of tangentionally
migrating like cells up to second half of gestation be-
comes more important in the view that radial migration
has decreased substantionaly. This suggests that inten-
sive production of interneurons continued into the sec-
ond half of gestation, while the production of projection
neurons is decreasing rapidly. In addition, the number of
cortical neurons that are produced by ganglionic emi-
nence seems to increase during midgestation. Such ob-
servation seems not to support previous hypothesis. It is
more likely that relatively increased number of cortical
interneurons is supported by protracted production of
neurons in ganglionic eminence, as appearance of dorsal
(pallial) production of interneurons. It is also possible
that huge dorsal production of interneurons in primate
brain is principally connected with production of some
specific interneuron subpopulation.
In conclusion, we have to mention that studies on cor-
tical GABA-ergic neurons development are very limited
in monkeys and humans. It is also obvious that research
performed in rodents will not provide sufficient evidence
to understand mode and tempo of interneuron develop-
ment in the human brain. Disturbances of the GABA-
ergic network are found in many neurological and psy-
chiatric disorders and some could result from altered
development53,85,212–237. Therefore, understanding of the
human specific mechanisms, that regulate the develop-
ment of GABA-ergic interneuron subtypes, is a crucial
pre-required step for future neurobiological studies of
these diseases. Therefore, we found that further research
of GABA-ergic neuron development in the primate brain
has to be highly encouraged.
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PORIJEKLO GABA-ERGI^KIH NEURONA U PREDNJEM MOZGU ^OVJEKA,
DRUGIH PRIMATA I NI@IH SISAVACA
S A @ E T A K
U ovom osvrtu pru`amo pregled novih spoznaja o porijeklu inhibicijskih neurona koji sintetiziraju GABA (gama-
amino-masla~nu kiselinu) u prednjem mozgu (prozencefalon) sisavaca, {to uklju~uje kranji mozak (telencefalon) i me-
|umozak (diencefalon). Zanimanje za GABA-ergi~ke neurone, koji u kori velikog mozga (korteksu) uglavnom odgo-
varaju neuronima lokalnih krugova (interneuronima), zna~ajno je poraslo u proteklom desetlje}u. Kao posljedica toga,
potpuno se promijenilo prija{nje vjerovanje, te su novi rezultati pokazali da se u ni`ih sisavaca svi hipokampalni i
gotovo svi kortikalni GABA-ergi~ki neuroni ra|aju u specifi~nom podru~ju, tzv. ganglijski bre`uljak, a ne lokalno u
proliferativnim slojevima uzdu` cijele ventrikularne stijenke telencefalona. Ganglijski bre`uljak, koji je zapravo po-
dru~je ventralnog (bazalnog) telencefalona gdje je izrazito zadebljan proliferativni-subventrikularni sloj, smatrao se
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izvorom neurona bazalnih ganglija i septalnih jezgara, dok su se proliferativni slojevi dorzalnog telencefalona smatrali
izvorom svih kortikalnih i hipokampalnih neurona. Tako|er se smatralo da se neuroni kre}u od proliferativnih slojeva
do svog kona~nog odredi{ta prvenstveno mehanizmima radijalne migracije, ali su novi podaci pokazali da je to slu~aj
samo za projekcijske glutamatergi~ke neurone. GABA-ergi~ki neuroni koriste mehanizam tangencijalne migracije, pre-
laze}i velike udaljenosti od ganglijskog bre`uljka do svih dijelova kore velikoga mozga kre}u}i se paralelno s pijalnom
povr{inom. Posebno intrigantni, ali uglavnom zanemareni, su podaci o razlikama u porijeklu GABA-ergi~kih neurona
koje se javljaju tijekom evolucije u sisavaca. U ovom radu posebno smo se usredoto~ili na specifi~na doga|anja tijekom
razvoja GABA-ergi~kih neurona majmuna i ~ovjeka. U ve}ini neurolo{kih i psihijatrijskih bolesti dolazi do odstupanja
unutar GABA-ergi~ke mre`e neurona, prvenstveno kao posljedica poreme}enog razvoja. Zbog toga je za razumijevanje
neurobiologije ovih poreme}aja potrebno istra`iti mehanizme specifi~ne ~ovjeku koji reguliraju razvoj razli~itih pod-
vrsta GABA-ergi~kih interneurona.
Z. Petanjek et al.: Origin of GABA-ergic Neurons in Mammalian Forebrain, Coll. Antropol. 32 (2008) Suppl. 1: 9–17
17
